Jean-Pierre Garnier, Chairman of the Board of Directors

“After a very successful two decades, resulting in an unprecedented share price increase of more than 2’000% since our IPO, the next chapter for Actelion awaits. With the successful tender offer by Johnson & Johnson, regulatory approvals on track, and today’s approval by the shareholders to spin-out Idorsia, the transaction is moving ahead at full steam. I am confident that under Johnson & Johnson’s leadership, Actelion will continue to grow and prosper. At the same time, I am excited about the creation of Idorsia, and look forward to publishing results of the innovative pipeline in the coming months.”

Image library